SEC Filing Summary: Ares Acquisition Corporation II (AACT)
Business Context and Reporting Period
This Form 8-K, dated April 16, 2025, reports on Ares Acquisition Corporation II (AACT), a Cayman Islands-based special purpose acquisition company (SPAC). The filing details a material definitive agreement to extend the deadline for consummating a business combination with Kodiak Robotics, Inc. (Kodiak). The current deadline is April 25, 2025, and the proposed extension moves this date to January 26, 2026.
Key Financial Metrics and Capital Structure
The filing does not provide historical revenue, profit, or cash flow data as AACT is a pre-business combination SPAC. Key financial terms disclosed include:
- Trust Contributions: The Sponsor (Ares Acquisition Holdings II LP) agreed to deposit $0.02 per outstanding Class A ordinary share (excluding shares held by the Sponsor upon conversion) into the trust account monthly.
- Promissory Note: In exchange for contributions, the Company will issue a non-interest bearing, unsecured promissory note to the Sponsor.
- Share Capitalization: Following the proposed conversion of 12,500,000 Class B Ordinary Shares to Class A Ordinary Shares by the Sponsor, the Company expects 62,500,000 Class A Ordinary Shares outstanding (assuming no redemptions).
- Warrant Exercise Price: Redeemable warrants are exercisable at $11.50 per share.
Material Changes and Agreements
The primary material change is the entry into an agreement to extend the business combination deadline contingent upon shareholder approval. Key components include:
- Extension Proposal: Shareholders will vote on April 22, 2025, to amend the Memorandum and Articles of Association to extend the combination deadline from April 25, 2025, to January 26, 2026.
- Share Conversion: The Sponsor intends to convert 12,500,000 Class B Ordinary Shares into Class A Ordinary Shares prior to or concurrently with the shareholder vote. These shares will remain subject to existing restrictions, including waiver of redemption rights.
- Repayment Terms: The Promissory Note is repayable on the "Maturity Date" (the earlier of the business combination consummation or the final deadline). It may be prepaid without penalty.
Outlook, Risks, and Contingencies
Management's outlook is contingent on the successful approval of the Extension Amendment Proposal and the subsequent consummation of the business combination with Kodiak. Significant risks and contingencies identified include:
- Shareholder Approval: Failure of shareholders to adopt the Extension Amendment Proposal would likely result in liquidation.
- Redemptions: The amount of redemption requests by public equity holders could impact the capitalization of the combined company.
- Regulatory and Transaction Risks: Delays or failure to obtain regulatory approvals, or failure to realize anticipated benefits of the combination.
- Forward-Looking Statements: The filing explicitly disclaims any obligation to update forward-looking statements regarding the timing or success of the business combination.
Investor Verification Checklist
- Verify the outcome of the Shareholder Meeting scheduled for April 22, 2025, regarding the Extension Amendment Proposal.
- Confirm the final number of shares outstanding after accounting for any redemptions at the shareholder meeting.
- Review the definitive proxy statement/prospectus (Form S-4) for detailed terms of the business combination with Kodiak Robotics, Inc.
- Monitor the status of regulatory approvals required for the proposed business combination.
- Check for any updates on the Sponsor's monthly contributions to the trust account following the extension approval.